Alx Oncology Holdings (ALXO) Assets Average (2020 - 2026)

Alx Oncology Holdings (ALXO) has 7 years of Assets Average data on file, last reported at $118.7 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 11.65% year-over-year to $118.7 million; the trailing twelve-month figure through Mar 2026 stood at $118.7 million (down 11.65% YoY), and the FY2025 full-year result was $103.4 million, down 47.01% from the prior year.
• Assets Average rose to $118.7 million in Q1 2026, from $70.9 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $371.9 million in Q1 2022 to a low of $70.9 million in Q4 2025.
• A 5-year average of $218.7 million and a median of $227.6 million in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average sank 57.49% in 2025 and declined 11.65% in 2026, its largest moves.
• Tracing ALXO's Assets Average over 5 years: stood at $312.1 million in 2022, then slipped by 25.88% to $231.3 million in 2023, then declined by 27.92% to $166.7 million in 2024, then slumped by 57.49% to $70.9 million in 2025, then jumped by 67.44% to $118.7 million in 2026.
• Business Quant data shows ALXO's Assets Average at $118.7 million in Q1 2026, $70.9 million in Q4 2025, and $89.0 million in Q3 2025.